BlockerLife

Health and family

U.S. overdose deaths fell for years before the White House’s claimed timeline

In reporting published on November 18, 2026, new Centers for Disease Control and Prevention data showed U.S. drug overdose deaths at their lowest level in roughly a decade. The White House credited policies under President Donald Trump for much of the decline, but researchers said the improvement began well before he returned to office.

The White House Office of National Drug Control Policy said total overdose deaths were approximately 41.5% below their peak under the previous administration. Its director, Sara Carter, attributed the decline to tighter border security and efforts against drug-trafficking organizations, saying the gains had occurred primarily over the preceding 18 months.

CDC data, however, showed overdose deaths declining for at least 39 consecutive months, beginning in 2023. Fatal overdoses had fallen by roughly one-third by the time President Joe Biden left office. Nabarun Dasgupta, a street-drug researcher at the University of North Carolina at Chapel Hill, said declines appeared in some regions and demographic groups as early as 2021; he identified early 2024 through spring 2025 as the period with the fastest decline.

Researchers interviewed for the report pointed to several possible contributors during the Biden administration, including wider access to health care and the overdose-reversal medication naloxone, a U.S.-China agreement concerning chemicals used to make fentanyl, and drug-interdiction efforts. They also said deaths continued to fall under Trump. The precise reasons for the rise in fentanyl deaths and the subsequent decline remain under study. Fentanyl was still the leading cause of drug deaths nationwide.

Asked about the earlier decline, Carter said Biden should not receive credit after presiding over historically high overdose numbers. She maintained that the Trump administration was building on the reductions and said it was dismantling drug-trafficking organizations. Brookings Institution researcher Vanda Felbab-Brown disputed that assessment, saying she could not identify a narco-terrorist organization that had been dismantled.

Dasgupta also raised concern about whether the decline could continue as Medicaid cuts take effect. The Congressional Budget Office estimated that the cuts could leave as many as 10 million Americans without health insurance. That estimate describes a potential coverage loss, not a measured effect on future overdose deaths.